TABLE 2.
Rex-2 proteins | Localizationa | RNA bindingb | Multimerization/trans dominantc | Shuttlingd |
---|---|---|---|---|
wtRex-2 | Nuc | + | +/− | + |
Rex-2 M1 | Nuc | + | +/− | + |
Rex-2 M5 | Nuc | + | −/+ | ± |
Rex-2 M10 | Nuc | + | −/+ | ± |
Rex-2 M14 | Nuc | + | −/+ | ± |
Rex-2 M16 | Nuc | + | +/− | ± |
Rex-2 M17 | Cyt | ± | NDe/− | NDe |
Rex-2 DD | Nuc | ++ | +/NDe | ± |
Rex-2 M18 | Nuc | + | +/− | + |
Rex-2 M19 | Nuc | + | +/− | ± |
Predominant subcellular localization. Nuc, nucleus and nucleolus; Cyt, cytoplasmic.
Positive (+), impaired (±), or enhanced (++) Rex binding to RxRE-containing RNA as determined by in vivo binding experiments.
Positive (+) or negative (−) for multimerization and trans-dominant capacity.
Positive (+) or impaired (±) for nucleocytoplasmic shuttling as determined by actinomycin D assays.
ND, not determined.